Clinical trial Recruiting at 1 site Observational Ages 6 to 40

Characterization of Multiple Osteochondromas Disorder

Official title: Misure di funzionalità e deformità Dell'Apparato Muscolo-scheletrico Come "Biomarkers" Per il Trattamento di Malattie Ortopediche/Accessible Measurements of Mobility and Deformity as Biomarkers for Orthopaedic Treatments

Run by Istituto Ortopedico Rizzoli · NCT06703736 · Data updated 2026-11-12

This study is testing how hereditary multiple osteochondromas affects people of all ages to improve treatment timing and quality of life, while also trying out new ways to measure joint movement and bone shape.

Quick facts

Study typeObservational
Ages6 Years to 40 Years
SexAll
Enrollment60 (estimated)
SponsorIstituto Ortopedico Rizzoli
Academic / other
Locations1 site (Bologna)
StatusRecruiting
StartedMay 21, 2025
Main results expectedSeptember 1, 2026
Study endsDecember 30, 2026
Registry record updatedMarch 24, 2026
Trial IDNCT06703736 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals aged 6-40 years with a clinical or molecular diagnosis of multiple osteochondromas, particularly those with lesions in the lower limbs.

Probably not a fit

Patients outside the specified age range or those without multiple osteochondromas or other significant limb-limiting conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to characterize the functional and morphological changes associated with hereditary multiple osteochondromas in both pediatric and adult populations. It will collect anthropometric and functional data to assess the disease holistically, which may inform the timing of surgical interventions and enhance patient quality of life. Additionally, the study seeks to validate new tools for measuring joint mobility and bone deformity, designed for ease of use by patients and minimally trained operators. The ultimate goal is to evaluate the quality of life and balance perception in affected individuals.

Why it matters

Potential benefit: If successful, this study could lead to improved assessment and management strategies for patients with hereditary multiple osteochondromas, enhancing their quality of life.

How similar studies have gone: While there is limited literature on the instrumental characterization of osteochondromas, the holistic approach of this study is novel and may pave the way for future advancements in understanding this condition.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

For multiple osteochondromas cohort inclusion criteria are:

* clinical and/or molecular diagnosis of Multiple Osteochondromas;
* male and female subjects;
* age minors: 6-17 years at enrollment and adult age: 18-40 years at enrollment;
* collection of appropriate informed consent;
* ability to walk a linear path without aids;
* presence of multiple osteochondromas localized at lower limbs;
* ability to undergo all procedures required by the protocol.

For healthy cohort inclusion criteria are:

* absence of neuro-muskuloskeletal or other limb-limiting conditions in the lower limbs;
* male and female subjects;
* age minors: 6-17 years at enrollment and adult age: 18-40 years at enrollment;
* collection of appropriate informed consent;
* ability to undergo all procedures required by the protocol.

Exclusion Criteria:

* Persons who do not fit the inclusion criteria;
* Any reason which, in the opinion of the investigator, would result in the inability of the participant to comply with the protocol.
* BMI equal to or greater than 30.

Where it's running

  • IRCCS Istituto Ortopedico Rizzoli
    Bologna, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.